News

According to investigators, a key reason for the link may lie in circadian “clocks,” the molecular machinery within every cell of every organism, which have evolved to adapt to daily stresses, such as changes in light and temperature caused by the rising and setting of the sun.

The company announced it has received FDA IND clearance for linsitinib and prepares to initiate Phase 2b clinical trial.

By co-culturing the differentiated microglia with retinal organoids, investigators found they may be able to recapitulate retinal development.

Increasing understanding of the genetics behind Usher syndrome suggests that treatment may become possible in the very near future.

After 10 years, AREDS2 formula shows increased efficacy compared to original formula, benefit of eliminating beta-carotene.

The research is the result of a national collaboration led by investigators from the Centre for Eye Research Australia at the University of Melbourne and University of Tasmania and the Garvan Institute of Medical Research.

With clearer imaging and enhanced resolution, the new OCT approach could improve medical diagnostic imaging.

According to the company, no safety concerns with corneal endothelial health reported across all 3 trials, and the device delivered consistent results up to two-year follow-up in patients across Central and South America, Asia and Europe.

Genetic and clinical research reveals new type of macular dystrophy, a cause of central vision loss.

John Cooksey, who had an ophthalmology practice in Monroe, Louisiana, served three terms in the US House of Representatives. He also founded an eye clinic in Kenya.

Study demonstrates results of pegcetacoplan as a geographic atrophy therapy.

As special pandemic rules end, a new analysis shows the potential impact on patients in some states and rural areas of others.

Retina specialists and their patients have learned how AI and telemedicine can be effective in monitoring disease progression and alerting clinicians to early signs of adverse changes.

A team of investigators is researching the use of a new cell delivery method to help cells stick and stay where they are needed most.

According to the study by a team of researchers from the University of California Irvine and University of Southern California, treatment with Humanin G reduced protein levels of inflammation markers that become elevated in age-related macular degeneration.

After 10 years, AREDS2 formula shows increased efficacy compared to original formula, benefit of eliminating beta-carotene.

Scientists have revived light-sensing neuron cells in organ donor eyes and restored communication between them as part of a series of discoveries that stand to transform brain and vision research.

Physicians can use navigational tools to attain a much more immersive perspective.

With clearer imaging and enhanced resolution, the new OCT approach could improve medical diagnostic imaging.

Biologic treatments can be utilised to help the eye heal itself in inflammatory conditions such as dry eye disorder.

The rare disorder is often a delayed or misdiagnosed condition, resulting in unnecessary referrals and imaging.

According to the study by a team of researchers from the University of California Irvine and University of Southern California, treatment with Humanin G reduced protein levels of inflammation markers that become elevated in age-related macular degeneration.

The study will investigate the safety, tolerability, pharmacokinetics, and efficacy of AM712 in subjects with neovascular age-related macular degeneration.

On this week's episode of the NeuroOp Guru, Andy Lee, MD, and Elizabeth Fortin, MD, discuss the current status of eye stroke evaluations for CRAO.

Vision Buddy is offering a headset that features modes for TV/movie streaming, magnification, and reading, helping the visually impaired improve their quality of life.

Biogen and Samsung Bioepis announce the launch of ranibizumab-nuna and detail when the ophthalmic biosimilar will be available for retina specialists.